Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 5,178 | 3,815 | 3,135 | 2,963 | 2,558 |
| Cost of Goods | 1,537 | 1,364 | 1,295 | 1,096 | 957 |
| Gross Profit | 3,641 | 2,451 | 1,840 | 1,868 | 1,601 |
| Operating Expenses | 2,893 | 2,675 | 2,353 | 1,996 | 2,899 |
| Operating Income | 1,285 | 140 | -218 | -32 | -341 |
| Interest Expense | 1 | 1 | 1 | 1 | 105 |
| Other Income | -145 | -136 | -338 | -285 | -322 |
| Pre-tax Income | 1,139 | 3 | -558 | -319 | -768 |
| Net Income Continuous | 1,139 | 3 | -558 | -319 | -768 |
| Net Income | $1,139 | $3 | $-558 | $-319 | $-768 |
| EPS Basic Total Ops | 0.07 | -0.01 | -0.05 | -0.03 | -0.06 |
| EPS Basic Continuous Ops | 0.08 | 0.00 | -0.04 | -0.02 | -0.06 |
| EPS Diluted Total Ops | 0.05 | -0.01 | -0.05 | -0.03 | -0.06 |
| EPS Diluted Continuous Ops | 0.06 | 0.00 | -0.04 | -0.02 | -0.06 |
| EBITDA(a) | $1,337 | $186 | $-171 | $87 | $-224 |